VCID: 133291
    Profile

    Corporate information

    Official name
    Remeditex Ventures Limited Liability Company
    Investment activity status
    Active investor

    Selected investments

    Country Date Notes
    Miragen Therapeutics Inc
    Ddeveloper of cardiovascular and muscle disease therapeutics based on microRNA biology.
    United States 1 Apr 2012 Series B
    Initial investment. Round participant. Active
    Bellicum Pharmaceuticals Inc
    Clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer.
    United States N/A

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.